)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Lucid Diagnostics (LUCD) investor relations material
Lucid Diagnostics Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary5 Dec, 2025
Company overview and business model
Commercial-stage medical diagnostics technology company focused on early detection and prevention of esophageal precancer and cancer, particularly esophageal adenocarcinoma (EAC).
Flagship products include the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device, both based on patented technology licensed from Case Western Reserve University.
EsoGuard is a next-generation sequencing DNA assay with ~90% sensitivity and ~99% negative predictive value for detecting esophageal precancer and cancer.
EsoCheck is an FDA 510(k) and CE Mark cleared, noninvasive, swallowable balloon capsule device for targeted esophageal cell collection.
Majority-owned subsidiary of PAVmed, with corporate headquarters in New York, NY.
Financial performance and metrics
Has incurred operating losses since inception and has not achieved profitability.
Substantial doubt exists regarding ability to continue as a going concern, as noted by the independent auditor.
September 2025 public offering raised net proceeds of approximately $27.0 million from the sale of 28,750,000 shares at $1.00 per share.
As of December 1, 2025, 137,683,002 shares of common stock and 54,274 shares of preferred stock were outstanding.
Net tangible book value as of September 30, 2025 was $0.19 per share; pro forma as adjusted after the offering, $0.32 per share.
Use of proceeds and capital allocation
Net proceeds from offerings are intended for working capital and general corporate purposes.
Management has broad discretion over the use of proceeds, with no specific allocations identified.
Pending application, proceeds may be held in cash, cash equivalents, or short-term investments.
Future dilution impact from existing convertibles?
What is the next step for EsoGuard Medicare coverage?
How does PAVmed's influence affect company strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Lucid Diagnostics earnings date
Q4 202525 Mar, 2026
Next Lucid Diagnostics earnings date
Q4 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Lucid Diagnostics Inc. is a medical diagnostics company focused on the early detection of esophageal precancer and cancer. The company develops and commercializes diagnostic tests that aim to identify patients at risk of esophageal adenocarcinoma, a cancer often associated with gastroesophageal reflux disease (GERD) and Barrett’s esophagus. Lucid's lead product, the EsoCheck diagnostic device, is designed to collect esophageal cells in a non-invasive procedure for further analysis using its EsoGuard test, which detects genetic changes associated with cancer risk. The company’s technology provides a less invasive alternative to traditional diagnostic methods like endoscopy. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage